P1: LMD/GGT P2: GCR/LOV QC:
Psychiatric Quarterly [psaq] ph071-psaq-346684 November 7, 2001 8:31 Style ﬁle version Nov. 19th, 1999
Psychiatric Quarterly, Vol. 73, No. 1, Spring 2002 (
OF PATIENTS WITH HIV AND AIDS
Stephen J. Ferrando, M.D., and Khakasa Wapenyi, M.D.
Psychopharmacological treatment of patients with HIV/AIDS is an important
aspect of managing distress and enhancing quality of life. This article re-
views the psychopharmacological management of depression, anxiety, mania,
and psychosis in the context of HIV/AIDS, with a discussion of psychotropic–
antiretroviral drug interactions. While psychopharmacological management of
HIV/AIDS patients may be complex, there is a substantial amount of clinical
and research information describing both conventional and novel approaches
that are safe and effective.
KEY WORDS: HIV; AIDS; psychopharmacology; drug interactions.
Knowledge of psychopharmacology is critical to the management of
patients with HIV infection, due to the prevalence of premorbid psy-
chopathology and substance abuse, HIV-associated neurocognitive
The authors are afﬁliated with New York Presbyterian Hospital, Weill Medical College
of Cornell University.
Address correspondence to Stephen J. Ferrando, M.D., Psychiatry Consultation-Liaison
Service, New York Presbyterian Hospital, 525 E. 68
Street, Box 181, New York, New
York 10021; e-mail: firstname.lastname@example.org.
2002 Human Sciences Press, Inc.